We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Ranked Momentum Stocks to Buy for September 24th
Read MoreHide Full Article
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 24th:
RH (RH - Free Report) : This retailer of home furnishings has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 46.4% over the last 60 days.
Ready Capital Corporation (RC - Free Report) : This real estate finance company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 29.5% over the last 60 days.
Salesforce.com, inc. (CRM - Free Report) : This enterprise cloud computing solutions developer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25.9% over the last 60 days.
PennyMac Financial Services, Inc. (PFSI - Free Report) : This mortgage banking and investment management company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 48% over the last 60 days.
PennyMac Financial Services, Inc. Price and Consensus
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for September 24th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 24th:
RH (RH - Free Report) : This retailer of home furnishings has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 46.4% over the last 60 days.
RH Price and Consensus
RH price-consensus-chart | RH Quote
RH’s shares gained 9.8% over the last one month compared with the S&P 500’s decline of 4.7%. The company possesses a Momentum Score of A.
RH Price
RH price | RH Quote
Ready Capital Corporation (RC - Free Report) : This real estate finance company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 29.5% over the last 60 days.
Ready Capital Corp Price and Consensus
Ready Capital Corp price-consensus-chart | Ready Capital Corp Quote
Ready Capital’s shares gained 16.3% over the last one month. The company possesses a Momentum Score of A.
Ready Capital Corp Price
Ready Capital Corp price | Ready Capital Corp Quote
Salesforce.com, inc. (CRM - Free Report) : This enterprise cloud computing solutions developer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25.9% over the last 60 days.
salesforce.com, inc. Price and Consensus
salesforce.com, inc. price-consensus-chart | salesforce.com, inc. Quote
Salesforce’s shares gained 13.7% over the last one month. The company possesses a Momentum Score of A.
salesforce.com, inc. Price
salesforce.com, inc. price | salesforce.com, inc. Quote
PennyMac Financial Services, Inc. (PFSI - Free Report) : This mortgage banking and investment management company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 48% over the last 60 days.
PennyMac Financial Services, Inc. Price and Consensus
PennyMac Financial Services, Inc. price-consensus-chart | PennyMac Financial Services, Inc. Quote
PennyMac Financial Services’ shares gained 15.3% over the last one month. The company possesses a Momentum Score of A.
PennyMac Financial Services, Inc. Price
PennyMac Financial Services, Inc. price | PennyMac Financial Services, Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Momentum score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>